• Village Farms International Leads with 275% Return in Recent Performance Surge Markets Mojo Mon, 17 Nov 2025 19:28:26 GMT
• Avenue Therapeutics Leads Six-Month Stock Performance with 333.85% Return Markets Mojo Fri, 14 Nov 2025 18:51:08 GMT
• fortress biotech reports third quarter 2025 financial results and recent corporate highlights The Manila Times Fri, 14 Nov 2025 13:33:40 GMT
• Avenue Therapeutics Reports Improved Financials Amid Challenges TipRanks Fri, 14 Nov 2025 04:39:28 GMT
• village farms international leads six-month stock performance with 424.66% return Markets Mojo Thu, 13 Nov 2025 18:43:28 GMT
• ATXI SEC Filings - Avenue Therapeutics Inc 10-K, 10-Q, 8-K Forms Stock Titan Wed, 12 Nov 2025 13:00:52 GMT
• rbc capital sticks to their buy rating for axsome therapeutics (axsm) The Globe and Mail Wed, 12 Nov 2025 08:15:00 GMT
• Village Farms International Leads with 354.34% Return in Recent Performance Markets Mojo Mon, 10 Nov 2025 17:00:09 GMT
• axsome therapeutics acquires baergic bio from avenue therapeutics MSN Mon, 10 Nov 2025 12:25:20 GMT
• Axsome Therapeutics acquires Baergic Bio from Avenue Therapeutics MSN Sun, 09 Nov 2025 20:49:32 GMT
• axsome therapeutics buys global rights to azd7325 to expand epilepsy pipeline Pulse 2.0 Sat, 08 Nov 2025 15:40:30 GMT
• axsome therapeutics acquires baergic bio from avenue therapeutics MSN Sat, 08 Nov 2025 10:50:22 GMT
• shore capital reaffirms their buy rating on astrazeneca (azn) The Globe and Mail Fri, 07 Nov 2025 17:06:42 GMT
• avenue shares rights to epilepsy drug candidate with axsome in deal Investing.com Nigeria Fri, 07 Nov 2025 08:05:40 GMT
• Avenue Therapeutics (ATXI) Sells Baergic Bio to Axsome Therapeutics GuruFocus Thu, 06 Nov 2025 15:07:18 GMT
• axsome therapeutics acquires baergic bio from avenue therapeutics MSN Thu, 06 Nov 2025 14:18:44 GMT
• axsome therapeutics acquires subtype selective gaba-a receptor positive allosteric modulator azd7325 for the treatment of epilepsy... Sahm Thu, 06 Nov 2025 12:00:00 GMT
• avenue (otc: atxi): axsome to acquire baergic; up to $82m milestones, royalties Stock Titan Thu, 06 Nov 2025 12:00:00 GMT
• press release: avenue therapeutics announces acquisition of subsidiary baergic bio by axsome therapeutics 富途牛牛 Thu, 06 Nov 2025 12:00:00 GMT
• Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• Axsome adds AstraZeneca epilepsy candidate to pipeline through Avenue subsidiary acquisition Fierce Biotech Thu, 06 Nov 2025 08:00:00 GMT
• avenue shares rights to epilepsy drug candidate with axsome in deal Investing.com Thu, 06 Nov 2025 08:00:00 GMT
• avenue therapeutics announces baergic bio acquisition by axsome TipRanks Thu, 06 Nov 2025 08:00:00 GMT
• Head to Head Survey: Avenue Therapeutics (NASDAQ:ATXI) vs. Neoleukin Therapeutics (NASDAQ:NLTX) Defense World Thu, 16 Oct 2025 07:00:00 GMT
• avenue therapeutics (nasdaq:atxi) vs. advanz pharma (otcmkts:cxrxf) financial analysis Defense World Wed, 15 Oct 2025 05:29:21 GMT
• xtrackers msci kokusai equity etf (nysearca:koku) trading 1.4% higher – still a buy? Defense World Tue, 14 Oct 2025 07:00:00 GMT
• relmada therapeutics (nasdaq:rlmd) upgraded at wall street zen MarketBeat Sat, 11 Oct 2025 07:00:00 GMT
• unusual brain cell type linked to progressive ms, could point to therapeutics Genetic Engineering and Biotechnology News Fri, 10 Oct 2025 07:00:00 GMT
• speedy hire (lon:sdy) shares up 18.8% following insider buying activity Defense World Tue, 07 Oct 2025 07:00:00 GMT
• park avenue securities llc has $212,000 holdings in madrigal pharmaceuticals, inc. $mdgl Defense World Thu, 02 Oct 2025 07:27:59 GMT
• united therapeutics corporation $uthr stake lifted by park avenue securities llc Defense World Mon, 29 Sep 2025 10:35:32 GMT
• park avenue securities llc has $622,000 stock position in halozyme therapeutics, inc. $halo Defense World Mon, 29 Sep 2025 07:00:00 GMT
• avenue therapeutics announces outcome of fda advisory committee meeting on iv tramadol IT Business Net Thu, 18 Sep 2025 16:28:00 GMT
• cognition therapeutics (nasdaq:cgtx) raised to hold at wall street zen MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
• dietary changes could provide a therapeutic avenue for brain cancer The Good Men Project Mon, 08 Sep 2025 00:33:45 GMT
• dietary changes could provide a therapeutic avenue for brain cancer The Good Men Project Sun, 07 Sep 2025 07:00:00 GMT
• neurology biopharmas rebound on trial catalysts and q2 gains BioWorld MedTech Fri, 05 Sep 2025 07:00:00 GMT
• dietary changes could provide a therapeutic avenue for brain cancer | newswise Newswise Thu, 04 Sep 2025 07:00:00 GMT
• Dietary changes could provide a therapeutic avenue for brain cancer michiganmedicine.org Wed, 03 Sep 2025 07:00:00 GMT
• coya therapeutics to participate at upcoming september investor conferences Stock Titan Wed, 03 Sep 2025 07:00:00 GMT
• precise progerin targeting using rfxcas13d: a therapeutic avenue for hutchinson-gilford progeria syndrome ScienceDirect.com Wed, 03 Sep 2025 07:00:00 GMT
• fbio in focus - will cutx-101 make history as the first fda-approved menkes disease therapy? RTTNews Fri, 29 Aug 2025 07:00:00 GMT
• avenue therapeutics reports positive earnings amid challenges TipRanks Fri, 22 Aug 2025 03:58:50 GMT
• avenue therapeutics reports positive earnings amid challenges TipRanks Thu, 21 Aug 2025 07:00:00 GMT
• potential new therapeutic avenue identified in mf care Hematology Advisor Fri, 15 Aug 2025 04:00:00 GMT
• here’s third avenue small-cap value fund’s update on supernus pharmaceuticals (supn) Yahoo Finance Mon, 11 Aug 2025 07:00:00 GMT
• new to the street client nrx pharmaceuticals (nasdaq:nrxp) secures fda fast track designation for nrx-100, expanding reach to 13 m... Newswire :) Press Release Distribution Mon, 11 Aug 2025 07:00:00 GMT
• abeona therapeutics amends loan agreement with avenue The Globe and Mail Sat, 19 Jul 2025 07:00:00 GMT
• abeona therapeutics lowers loan interest rate and issues warrants in loan amendment Investing.com Fri, 18 Jul 2025 07:00:00 GMT
• targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance Nature Fri, 18 Jul 2025 07:00:00 GMT
• microglial modulation as a therapeutic avenue for perioperative neurocognitive disorders: unveiling pathophysiological mechanisms ... Wiley Online Library Fri, 18 Jul 2025 07:00:00 GMT
• targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance Nature Thu, 17 Jul 2025 23:34:00 GMT
• delisting of securities from the nasdaq stock market The Manila Times Sat, 12 Jul 2025 07:00:00 GMT
• Nasdaq Announces Delisting of Multiple Companies Including NKGen Biotech, Aquaron Acquisition Corp, and Others Quiver Quantitative Fri, 11 Jul 2025 07:00:00 GMT
• delisting of securities from the nasdaq stock market The Globe and Mail Fri, 11 Jul 2025 07:00:00 GMT
• bronstein, gewirtz & grossman, llc notifies investors of avenue therapeutics, inc. (atxi) investigation ACCESS Newswire Thu, 26 Jun 2025 14:54:10 GMT
• is avenue therapeutics, inc. technically bullish or bearish? MarketsMojo Wed, 25 Jun 2025 08:55:15 GMT
• TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX) Seeking Alpha Wed, 25 Jun 2025 07:00:00 GMT
• annji pharmaceutical announced a licensing agreement with avenue therapeutics to develop and commercialize aj201, a first-in-class... The Globe and Mail Sun, 22 Jun 2025 14:00:35 GMT
• annji pharmaceutical announced a licensing agreement with avenue therapeutics to develop and commercialize aj201, a first-in-class... The Globe and Mail Thu, 19 Jun 2025 15:02:15 GMT
• targeting acetylcholinesterase with oxytocin: a new avenue in alzheimer’s disease therapeutics ACS Publications Wed, 18 Jun 2025 07:18:45 GMT
• recce pharmaceuticals announces non-dilutive financing via facility with avenue capital group BiotechDispatch Tue, 17 Jun 2025 07:00:00 GMT
• targeting acetylcholinesterase with oxytocin: a new avenue in alzheimer’s disease therapeutics ACS Publications Tue, 17 Jun 2025 07:00:00 GMT
• park avenue securities llc invests $259,000 in corcept therapeutics incorporated (nasdaq:cort) Defense World Mon, 16 Jun 2025 07:00:00 GMT
• park avenue securities llc has $713,000 holdings in united therapeutics co. (nasdaq:uthr) Defense World Sat, 14 Jun 2025 07:00:00 GMT
• park avenue securities llc increases stake in halozyme therapeutics, inc. (nasdaq:halo) Defense World Fri, 13 Jun 2025 07:49:45 GMT
• safety scares and trial misses drag down neuro biotechs into q2 BioWorld MedTech Fri, 13 Jun 2025 07:00:00 GMT
• jane street group llc makes new investment in neurosense therapeutics ltd. (nasdaq:nrsn) Defense World Mon, 09 Jun 2025 07:10:34 GMT
• aj201 shows good safety, hints of efficacy in sbma clinical trial SMA News Today Fri, 23 May 2025 07:00:00 GMT
• patient-derived models of uba5-associated encephalopathy identify defects in neurodevelopment and highlight potential therapeutic ... Science | AAAS Wed, 07 May 2025 07:00:00 GMT
• avenue therapeutics stock hits 52-week low at $1.5 amid challenges MSN Sun, 04 May 2025 23:00:50 GMT
• exploiting haem-iron dependence of nontypeable haemophilus influenzae: an avenue for future therapeutic development Frontiers Wed, 23 Apr 2025 01:02:29 GMT
• qrich1 protein discovery opens new avenues for cancer and autoimmune therapies News-Medical Wed, 09 Apr 2025 07:00:00 GMT
• Mitochondrial Protein Discovery Offers Avenue for Alzheimer's Therapeutics Technology Networks Tue, 08 Apr 2025 07:00:00 GMT
• Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings Stock Titan Mon, 31 Mar 2025 07:00:00 GMT
• fortress biotech reports 2024 financial results and recent corporate highlights GlobeNewswire Mon, 31 Mar 2025 07:00:00 GMT
• entwistle & cappucci llp is investigating potential federal securities law violations in connection with cerevel therapeutics hold... Business Wire Mon, 31 Mar 2025 07:00:00 GMT
• unpacking q4 earnings: pfizer (nyse:pfe) in the context of other branded pharmaceuticals stocks The Globe and Mail Thu, 27 Mar 2025 09:06:00 GMT
• exp world (expi): buy, sell, or hold post q4 earnings? The Globe and Mail Wed, 26 Mar 2025 09:14:00 GMT
• exploring new avenues for treating muscular dystrophies with targeted therapies: matthew alexander, phd Neurology live Tue, 25 Mar 2025 07:00:00 GMT
• 1 technology etf to buy hand over fist and 1 to avoid The Globe and Mail Sun, 23 Mar 2025 08:55:00 GMT
• dow dips over 200 points; us industrial production increases more than expected Benzinga Tue, 18 Mar 2025 07:00:00 GMT
• avenue therapeutics, inc. - common stock (nasdaq:atxi) stock quote FinancialContent Tue, 18 Mar 2025 07:00:00 GMT
• why harrow shares are trading higher by 23%; here are 20 stocks moving premarket Benzinga Tue, 18 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in tuesday's pre-market session Benzinga Tue, 18 Mar 2025 07:00:00 GMT
• avenue therapeutics, inc. (nasdaq:atxi) sees large decline in short interest Defense World Mon, 17 Mar 2025 07:00:00 GMT
• avenue therapeutics earnings preview: recent $atxi insider trading, hedge fund activity, and more Nasdaq Sat, 15 Mar 2025 07:00:00 GMT
• avenue therapeutics inc expected to post a loss of 57 cents a share - earnings preview TradingView Fri, 14 Mar 2025 07:00:00 GMT
• pharmacological landscape of endoplasmic reticulum stress: uncovering therapeutic avenues for metabolic diseases ScienceDirect.com Thu, 13 Mar 2025 12:16:11 GMT
• 12 health care stocks moving in thursday's pre-market session Benzinga Thu, 13 Mar 2025 12:09:33 GMT
• avenue therapeutics stock hits 52-week low at $0.9 amid downturn Investing.com Thu, 13 Mar 2025 07:00:00 GMT
• avenue therapeutics annji intends to terminate license agreement with co -march 07, 2025 at 04:36 pm est Marketscreener.com Fri, 07 Mar 2025 21:39:34 GMT
• avenue therapeutics granted nasdaq extension, faces annji dispute Investing.com Fri, 07 Mar 2025 08:00:00 GMT
• intra-cellular deal, axsome settlement drive neurological index recovery BioWorld MedTech Fri, 07 Mar 2025 08:00:00 GMT
• postoperative pain market forecasted to surge in coming years, openPR Mon, 03 Mar 2025 19:34:00 GMT
• avenue therapeutics, inc. (nasdaq:atxi) short interest down 40.5% in february Defense World Mon, 03 Mar 2025 07:53:09 GMT
• avenue therapeutics, inc. (nasdaq:atxi) short interest down 40.5% in february Defense World Sun, 02 Mar 2025 08:00:00 GMT
• avenue therapeutics (nasdaq:atxi) vs. teva pharmaceutical industries (nyse:teva) head to head review Defense World Fri, 28 Feb 2025 08:00:00 GMT
• wedbush lowers earnings estimates for travere therapeutics Defense World Fri, 28 Feb 2025 06:26:49 GMT
• february’s top 3 stock upgrades: what investors need to know The Globe and Mail Tue, 25 Feb 2025 08:00:00 GMT
• letter: lubiprostone—a novel therapeutic avenue for gastrointestinal complications in masld Wiley Online Library Tue, 18 Feb 2025 08:00:00 GMT
• avenue therapeutics stock hits 52-week low at $1.5 amid challenges MSN Wed, 12 Feb 2025 11:22:30 GMT
• the surprise surge: how travere therapeutics defied wall street trends Jomfruland.net Wed, 12 Feb 2025 08:00:00 GMT
• avenue therapeutics reports full year 2023 financial results and recent corporate highlights br.ADVFN.com Tue, 11 Feb 2025 19:31:50 GMT
• microglial autophagic dysregulation in traumatic brain injury: molecular insights and therapeutic avenues ACS Publications Fri, 07 Feb 2025 08:00:00 GMT
• role of ox/oxr cascade in insomnia and sleep deprivation link alzheimer’s disease and parkinson’s disease: therapeutic avenue of d... ScienceDirect.com Thu, 06 Feb 2025 01:55:44 GMT
• avenue therapeutics stock hits 52-week low at $1.5 amid challenges Investing.com Australia Tue, 28 Jan 2025 08:00:00 GMT
• 13,028 shares in amicus therapeutics, inc. (nasdaq:fold) acquired by park avenue securities llc Defense World Mon, 27 Jan 2025 09:33:26 GMT
• park avenue securities llc buys shares of 1,684 sarepta therapeutics, inc. (nasdaq:srpt) Defense World Mon, 27 Jan 2025 09:33:21 GMT
• avenue therapeutics stock hits 52-week low at $1.5 amid challenges Investing.com Mon, 27 Jan 2025 08:00:00 GMT
• 12 health care stocks moving in monday's pre-market session Benzinga Mon, 27 Jan 2025 08:00:00 GMT
• park avenue securities llc buys new shares in springworks therapeutics, inc. (nasdaq:swtx) Defense World Mon, 27 Jan 2025 08:00:00 GMT
• exploring potassium channel inhibition: a promising avenue for brain tumor therapeutics BIOENGINEER.ORG Fri, 24 Jan 2025 08:00:00 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 24 Jan 2025 08:00:00 GMT
• avenue therapeutics inc (nasdaq: atxi) received an -51.98% loss in 6 months – here’s what to expect Marketing Sentinel Fri, 24 Jan 2025 08:00:00 GMT
• assenagon asset management s.a. sells 889,884 shares of 4d molecular therapeutics, inc. (nasdaq:fdmt) Defense World Wed, 22 Jan 2025 08:20:34 GMT
• united therapeutics co. (nasdaq:uthr) shares purchased by park avenue securities llc Defense World Wed, 22 Jan 2025 08:00:00 GMT
• coeptis therapeutics (nasdaq: coep) emerges as a biopharma innovator leveraging ai-driven marketing FinancialContent Fri, 17 Jan 2025 08:00:00 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 17 Jan 2025 08:00:00 GMT
• jane street group llc reduces holdings in aclaris therapeutics, inc. (nasdaq:acrs) Defense World Wed, 15 Jan 2025 08:00:00 GMT
• regeneron pharmaceuticals (nasdaq:regn) reaches new 12-month low after analyst downgrade Defense World Sat, 11 Jan 2025 08:00:00 GMT
• comparing galectin therapeutics (nasdaq:galt) and avenue therapeutics (nasdaq:atxi) Defense World Sat, 11 Jan 2025 06:46:02 GMT
• united therapeutics snaps up another property near silver spring hq Washington Business Journal Tue, 07 Jan 2025 08:00:00 GMT
• state street corp grows position in gyre therapeutics, inc. (nasdaq:gyre) Defense World Fri, 03 Jan 2025 08:00:00 GMT
• state street corp has $5.36 million holdings in zevra therapeutics, inc. (nasdaq:zvra) Defense World Mon, 30 Dec 2024 08:00:00 GMT
• neurological stocks rise and fall on clinical data; index down BioWorld MedTech Thu, 12 Dec 2024 08:00:00 GMT
• postoperative pain treatment market 2034: ema, pdma, fda approvals, medication, prevalence, therapies, clinical trials and compani... The Globe and Mail Wed, 11 Dec 2024 22:16:57 GMT
• janux therapeutics announces pricing of $350.0 million underwritten public offering of common stock and pre-funded warrants Business Wire Wed, 04 Dec 2024 08:00:00 GMT
• avenue therapeutics faces nasdaq delisting over equity shortfall by investing.com Investing.com Australia Sat, 30 Nov 2024 08:00:00 GMT
• Avenue Therapeutics faces Nasdaq delisting over equity shortfall Investing.com Fri, 29 Nov 2024 08:00:00 GMT
Avenue Therapeutics, Inc(NASDAQ:ATXI) 
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderatel...
Website: http://www.avenuetx.com
Founded: 2015
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology